论文部分内容阅读
1987年5月至1993年5月,我科共收治24例首次手术未达最佳缩瘤(残瘤>2cm)要求的晚期上皮性卵巢癌患者,其中14例给予化疗2~3疗程后进行了间歇性2次缩瘤术,均达最佳缩瘤之要求,术后残余瘤直径≤2cm,平均生存时间22.56月。未行2次缩瘤术的10例病人接受联合化疗,平均生存时间为13.40月,两者比较差异有显著性(P<0.05)。认为化疗次数是影响预后的因素(P<0.01),而病理类型、病理分级、年龄对生存时间无明显影响。
May 1987 to May 1993, our department received a total of 24 cases of patients with advanced epithelial ovarian cancer who did not meet the requirements of the first surgery less than the best tumor (residual tumor> 2cm), of which 14 patients were given chemotherapy after 2 to 3 courses Intermittent 2 times tumor reduction surgery, have reached the best requirements for tumor reduction, residual tumor diameter ≤ 2cm, the average survival time of 22.56 months. Ten patients who did not undergo 2 suture neoplasms received combined chemotherapy, with an average survival time of 13.40 months. There was a significant difference between the two groups (P <0.05). It is considered that the frequency of chemotherapy is the prognostic factor (P <0.01), while the pathological type, pathological grade and age have no significant effect on the survival time.